Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on August 13, 2026

13 hours ago

Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Indeterminate GlobeNewswire

13 hours ago

Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Indeterminate GlobeNewswire

13 hours ago

Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

Indeterminate GlobeNewswire

13 hours ago

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

13 hours ago

Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026

Indeterminate GlobeNewswire

13 hours ago

Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Indeterminate GlobeNewswire

13 hours ago

ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

13 hours ago

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

Indeterminate GlobeNewswire

13 hours ago

Mdxhealth Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

13 hours ago

ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

13 hours ago

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

Indeterminate GlobeNewswire

13 hours ago

JellyBlue Gummies Details Complete Supplement Facts Formulation for Male Vitality, Energy and Daily Wellness Support

Indeterminate GlobeNewswire

14 hours ago

FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies

Indeterminate GlobeNewswire

14 hours ago

Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success

Indeterminate GlobeNewswire

14 hours ago

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Indeterminate GlobeNewswire

15 hours ago

Carahsoft Partner Pavilion Showcases Federal Healthcare Innovations at Medicaid Enterprise Systems Conference 2026 in Portland, Ore., August 17-20

Indeterminate GlobeNewswire

15 hours ago

ATHENS ORTHOPEDIC CLINIC REINTRODUCES ORTHOPEDIC URGENT CARE NETWORK UNDER AOC ORTHONOW

Indeterminate GlobeNewswire

15 hours ago

IL-23 Inhibitors Gain Physician Preference for IBD Across Europe, Yet Actual Use Continues to Lag, According to Spherix Global Insights

Indeterminate GlobeNewswire

16 hours ago

UPDATE: Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

Indeterminate GlobeNewswire

16 hours ago

Type 1 Diabetes Risk Identified Up to Five Years Before Onset with More Than 92% Predictive Power in OTraces Analysis of TEDDY Study Data

Indeterminate GlobeNewswire